Get the Stockscreener App
5.48
8.05%
-0.48
After Hours:
5.58
0.10
+1.82%
Atai Life Sciences N V stock is traded at $5.48, with a volume of 6.44M.
It is down -8.05% in the last 24 hours and up +17.85% over the past month.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
See More
Previous Close:
$5.96
Open:
$6
24h Volume:
6.44M
Relative Volume:
1.07
Market Cap:
$1.17B
Revenue:
$2.59M
Net Income/Loss:
$-137.89M
P/E Ratio:
-6.7654
EPS:
-0.81
Net Cash Flow:
$-69.76M
1W Performance:
+0.55%
1M Performance:
+17.85%
6M Performance:
+285.92%
1Y Performance:
+352.89%
1-Day Range:
$5.475
$6.09
1-Week Range:
$5.06
$6.30
52-Week Range:
$1.04
$6.30
Atai Life Sciences N V Stock (ATAI) Company Profile
Name
Atai Life Sciences N V
Sector
Industry
Phone
49 89 2153 9035
Address
PROF. J.H. BAVINCKLAAN 7, AMSTELVEEN
Compare ATAI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ATAI
Atai Life Sciences N V
|
5.48 | 1.40B | 2.59M | -137.89M | -69.76M | -0.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Atai Life Sciences N V Stock (ATAI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-25 | Initiated | Oppenheimer | Outperform |
| Nov-18-24 | Reiterated | H.C. Wainwright | Buy |
| Apr-03-24 | Upgrade | Maxim Group | Hold → Buy |
| Nov-01-22 | Initiated | Loop Capital | Buy |
| Nov-30-21 | Initiated | Maxim Group | Buy |
| Nov-11-21 | Initiated | ROTH Capital | Buy |
| Oct-18-21 | Initiated | H.C. Wainwright | Buy |
| Sep-01-21 | Initiated | Jefferies | Buy |
| Jul-13-21 | Initiated | Berenberg | Buy |
| Jul-13-21 | Initiated | Canaccord Genuity | Buy |
| Jul-13-21 | Initiated | Cantor Fitzgerald | Buy |
| Jul-13-21 | Initiated | Citigroup | Buy |
| Jul-13-21 | Initiated | Cowen | Outperform |
| Jul-13-21 | Initiated | Credit Suisse | Outperform |
| Jul-13-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Jul-08-21 | Initiated | Aegis Capital | Buy |
View All
Atai Life Sciences N V Stock (ATAI) Latest News
Atai Life Sciences N.V. (ATAI) Stock Rebounds as Company Launches New Share Offering - parameter.io
ATAI Life Sciences and Beckley Psytech Announce FDA Breakthrough Therapy Designation for BPL-003 - TradingView
Atai Life Sciences Gets FDA Breakthrough Designation for Depression Treatment - MarketScreener
Can swing trading help recover from Atai Life Sciences N.V. lossesQuarterly Trade Review & Capital Efficient Trade Techniques - newser.com
atai Life Sciences Announces Proposed Public Offering of Common Shares - Yahoo
Atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression - MarketScreener
atai Life Sciences Receives FDA Breakthrough for BPL-003 in TRD | ATAI Stock News - Stock Titan
Ranking Atai Life Sciences N.V. among high performing stocks via toolsWeekly Risk Summary & Scalable Portfolio Growth Methods - newser.com
Combining machine learning predictions for Atai Life Sciences N.V.2025 Macro Impact & Real-Time Volume Analysis - newser.com
How high can Atai Life Sciences N.V. stock goPortfolio Return Report & Community Trade Idea Sharing - newser.com
Can technical indicators confirm Atai Life Sciences N.V.’s reversal2025 Earnings Surprises & Stepwise Trade Signal Guides - newser.com
Atai Life Sciences N.V. stock retracement – recovery analysisInsider Buying & Daily Entry Point Trade Alerts - newser.com
Psychedelic stocks up on remarks from GOP Senator (ATAI) - Seeking Alpha
How institutional ownership impacts Atai Life Sciences N.V. stockQuarterly Profit Report & AI Enhanced Market Trend Forecasts - newser.com
Atai Life Sciences Remains Undervalued, Analyst Initiates With Around 125% Stock Upside - Sahm
Atai Life Sciences N.V. stock chart pattern explainedQuarterly Market Summary & Low Risk High Reward Trade Ideas - newser.com
Tick level data insight on Atai Life Sciences N.V. volatilityQuarterly Profit Report & Risk Managed Investment Strategies - newser.com
Quantitative breakdown of Atai Life Sciences N.V. recent moveJuly 2025 Selloffs & Free AI Powered Buy and Sell Recommendations - newser.com
Can Atai Life Sciences N.V. stock resist sector downturnsJuly 2025 Pullbacks & Safe Capital Growth Plans - newser.com
How Atai Life Sciences N.V. (9VC) stock responds to job market shiftsGold Moves & Short-Term Trading Alerts - newser.com
Is now a turning point for Atai Life Sciences N.V.Profit Target & Verified Swing Trading Watchlists - newser.com
Needham Initiates ATAI Life Sciences N.V at Buy With $12 Price Target - MarketScreener
Needham Initiates Coverage of Atai Life Sciences N.V. (ATAI) with Buy Recommendation - Nasdaq
ATAI Life Sciences files update on Beckley Psytech acquisition plans By Investing.com - Investing.com Nigeria
ATAI Life Sciences files update on Beckley Psytech acquisition plans - Investing.com
ATAI Life Sciences to Acquire Beckley Psytech - TipRanks
ATAI Life Sciences N.V. Announces Acquisition of Beckley Psytech - TradingView
Published on: 2025-10-10 04:54:45 - newser.com
ATAI Life Sciences N.V. (ATAI) Stock Analysis: A Biotech Gem With 107% Potential Upside - DirectorsTalk Interviews
Can trapped investors hope for a rebound in Atai Life Sciences N.V.Portfolio Growth Summary & Low Risk Growth Stock Ideas - newser.com
What to expect from Atai Life Sciences N.V. in the next 30 daysJuly 2025 Selloffs & Technical Confirmation Trade Alerts - newser.com
Evaluating Atai Life Sciences N.V. with trendline analysis2025 Market Overview & Fast Moving Stock Trade Plans - newser.com
What sentiment indicators say about Atai Life Sciences N.V. stockJuly 2025 Volume & Expert Approved Momentum Ideas - newser.com
Will Atai Life Sciences N.V. stock outperform growth indexes2025 Market WrapUp & Safe Capital Growth Tips - newser.com
How to track smart money flows in Atai Life Sciences N.V.IPO Watch & Weekly Watchlist for Hot Stocks - newser.com
Using RSI to spot recovery in Atai Life Sciences N.V.July 2025 Intraday Action & Expert Verified Movement Alerts - newser.com
Short interest data insights for Atai Life Sciences N.V.2025 Growth vs Value & AI Powered Market Entry Strategies - newser.com
Momentum divergence signals in Atai Life Sciences N.V. chartPortfolio Growth Summary & Risk Managed Investment Signals - newser.com
Atai Life Sciences N V Stock (ATAI) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.96%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):